Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment–Elevation Myocardial Infarction
Wei Ren Chen, Yun Dai Chen, Feng Tian, et al.
Circulation Cardiovascular Imaging (2016) Vol. 9, Iss. 12
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Michael A. Nauck, Juris J. Meier, Matthew A. Cavender, et al.
Circulation (2017) Vol. 136, Iss. 9, pp. 849-870
Open Access | Times Cited: 498
DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways
Qinhua Jin, Ruibing Li, Nan Hu, et al.
Redox Biology (2017) Vol. 14, pp. 576-587
Open Access | Times Cited: 401
RETRACTED ARTICLE: NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2α
Hao Zhou, Jin Wang, Pingjun Zhu, et al.
Basic Research in Cardiology (2018) Vol. 113, Iss. 4
Closed Access | Times Cited: 284
Protective role of melatonin in cardiac ischemia‐reperfusion injury: From pathogenesis to targeted therapy
Hao Zhou, Qiang Ma, Pingjun Zhu, et al.
Journal of Pineal Research (2018) Vol. 64, Iss. 3
Open Access | Times Cited: 219
No-reflow phenomenon in the heart and brain
Robert A. Kloner, Kevin S. King, Michael G. Harrington
AJP Heart and Circulatory Physiology (2018) Vol. 315, Iss. 3, pp. H550-H562
Open Access | Times Cited: 182
Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury
Maija Dambrova, Coert J. Zuurbier, Vilmantė Borutaitė, et al.
Free Radical Biology and Medicine (2021) Vol. 165, pp. 24-37
Open Access | Times Cited: 121
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
Andrei C. Spósito, Otávio Berwanger, Luiz Sérgio Fernandes de Carvalho, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 125
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
María Isabel del Olmo-García, Juan Francisco Merino-Torres
Journal of Diabetes Research (2018) Vol. 2018, pp. 1-12
Open Access | Times Cited: 121
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
Pelin Golforoush, Derek M. Yellon, Sean M. Davidson
Basic Research in Cardiology (2020) Vol. 115, Iss. 6
Open Access | Times Cited: 84
Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes
Valerie D Heuvelman, Daniël H. van Raalte, Mark M. Smits
Cardiovascular Research (2019) Vol. 116, Iss. 5, pp. 916-930
Open Access | Times Cited: 82
Mitochondrial dysfunction and mitochondrial therapies in heart failure
Chennan Wu, Zhen Zhang, Weidong Zhang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106038-106038
Closed Access | Times Cited: 82
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
Johanna Helmstädter, Karin Keppeler, Leonie Küster, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 659-676
Open Access | Times Cited: 56
Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence
Paschalis Karakasis, Dimitrios Patoulias, George Kassimis, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 27, pp. 2109-2119
Closed Access | Times Cited: 8
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review
Silvano Dragonieri, Andrea Portacci, Vitaliano Nicola Quaranta, et al.
Diseases (2024) Vol. 12, Iss. 9, pp. 224-224
Open Access | Times Cited: 8
Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway
Huiying Qiao, Haiyan Ren, He Du, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 78
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence
Andrea Natali, Lorenzo Nesti, Domenico Tricò, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Treatment of Obesity in Mitigating Metabolic Risk
Sean Heffron, Johnathon Seth Parham, Jay Pendse, et al.
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1646-1665
Open Access | Times Cited: 49
How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?
Matthew M.Y. Lee, Mark C. Petrie, John J.V. McMurray, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 3, pp. 506-522
Open Access | Times Cited: 46
Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis
Dapeng Zhang, Li Xu, Lefeng Wang, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 45
Repurposing Antidiabetic Drugs for Cardiovascular Disease
Mario Schubert, Sinah Hansen, Julian Leefmann, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 42
Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives
Alessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 775-775
Open Access | Times Cited: 39
Cardiorenal mechanisms of action of glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors
David Z.I. Cherney, Jacob A. Udell, Daniel J. Drucker
Med (2021) Vol. 2, Iss. 11, pp. 1203-1230
Open Access | Times Cited: 34
Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
Carlota Fernandez Rico, Karidia Konate, Emilie Josse, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 27
Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury
Tiangui Yang, Daqing Zhang
Ageing Research Reviews (2023) Vol. 86, pp. 101884-101884
Closed Access | Times Cited: 13
SIRT6 deficiency in endothelial cells exacerbates oxidative stress by enhancing HIF1α accumulation and H3K9 acetylation at the Ero1α promoter
Zhenyang Guo, Xueting Yu, Shuang Zhao, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top